Table 3:

Population health and economic effects of scaling up radiotherapy capacity for cervical cancer treatment, 2015–35

	Health parameters			Human capital return on investment		Full income return on investment
	Patients requiring external-beam radiotherapy	Patients requiring brachytherapy	Life-years gained with radiotherapy scale-up	Nominal model	Efficient model	Nominal model	Efficient model
Base case values
Low-income countries	1 340 413	1 005 310	2 348 608	−0·4	0·3	0·3	1·8
Lower-middle-income countries	4 892 966	3 669 725	6 188 537	1·6	4·2	4·3	9·7
Upper-middle-income countries	3 120 872	2 340 654	2 861 813	6·1	12·3	14·2	27·7
Total	9 354 251	7 015 689	11 398 958	2·5	6·0	6·5	13·8
Sensitivity analysis: advanced stage distribution
Low-income countries	1 623 599	1 282 643	3 359 445	0·0	1·1	1·1	3·3
Lower-middle-income countries	5 926 692	4 682 086	9 655 660	3·0	7·0	7·2	15·4
Upper-middle-income countries	3 780 211	2 986 367	4 480 428	8·7	17·3	20·0	38·6
Total	11 330 502	8 951 096	17 495 533	4·0	9·5	9·9	22·1
Sensitivity analysis: integrated radiotherapy and vaccination scale-up
Low-income countries	1 284 243	963 183	2 041 140	−0·4	−0·1	0·3	0·9
Lower-middle-income countries	4 729 919	3 547 440	5 936 526	1·1	3·2	3·2	7·5
Upper-middle-income countries	3 014 362	2 260 772	2 694 691	5·6	11·4	13·4	25·87
Total	9 028 525	6 771 394	10 672 357	2·2	5·1	5·6	11·7

Return on investment is a ratio defined as the net present value (itself defined as the economic return on investment minus the cost of investment) divided by the cost of investment, all in US$.